- Report
- February 2025
- 130 Pages
Global
From €4584EUR$4,850USD£3,895GBP
- Report
- April 2023
- 110 Pages
Global
From €4489EUR$4,750USD£3,815GBP
The Liver Fluke Treatment market is a subset of the Liver and Kidney Disorders Drugs market. It is composed of drugs used to treat liver fluke infections, which are caused by parasitic flatworms. These drugs are used to treat the symptoms of the infection, such as abdominal pain, nausea, and fever, as well as to prevent the spread of the infection. Commonly used drugs include praziquantel, albendazole, and triclabendazole. These drugs are available in both oral and injectable forms.
The Liver Fluke Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline plc, Sanofi, Bayer AG, and Novartis AG. Show Less Read more